In addition, we used the TCGA database to analyze the relationship between SLC38A2 and pancreatic cancer prognosis and found that high expression of SLC38A2 was significantly correlated with poor prognosis (Fig. 6B, HR= 1.8, P= 0.01). Here, SLC38A2 is linked to pancreatic neoplasm.